News
6 Jul 2021
Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs
The acquisition will add peptide API development and manufacturing capabilities- Peptide drugs are growing significantly in oncology and metabolic therapies- Piramal’s integrated drug substance and drug product offering will now include peptides
Mentioned Companies
Piramal Pharma Solutions
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance